# Trade Mark Journal No.2026/009 27 February 2026

## WO0000001886982 (5,9,16,35,36,41,42,44)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:22 July 2025
Date of designation in the UK: 6 November 2025

Class 5
  Pharmaceutical preparations for the treatment of diabetes and obesity, pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for medical use.
Class 9
  Downloadable software in mobile applications for telehealth and telemedicine offerings for use by patients and healthcare professionals; downloadable software from websites for use by patients and healthcare professionals for the treatment of medical conditions; downloadable software for enabling patients to access general medical, health, and wellness information and advice; downloadable software for management and dispensing of medical prescriptions; software for location of healthcare professionals.
Class 16
  Instructional and teaching material.
Class 35
  Promoting public awareness about medical conditions; retail services in relation to pharmaceutical preparations; online ordering services relating to pharmaceutical preparations; business consultancy in the field of pharmaceutical delivery; online administration for pharmacies relating to the direct delivery of medicines to the patients.
Class 36
  Providing financial assistance to patients and healthcare providers for prescription pharmaceutical costs; providing information about patient reimbursement and insurance coverage for pharmaceuticals.
Class 41
  Educational services, namely, educational programmes, online electronic publication of reports, newsletters, and articles, online coaching and training services for patients and healthcare professionals related to the treatment of medical conditions.
Class 42
  Platform as a service featuring computer software to permit users to identify, request and receive pharmacy products.
Class 44
  Providing information in the field of management of medical conditions; charitable services, namely, patient assistance program to provide pharmaceuticals free of charge to low-income patients without prescription drug coverage.

Novo Nordisk A/S

Representative: CMS Cameron McKenna Nabarro Olswang LLP, Cannon Place, 78 Cannon St London EC4N 6AF UNITED KINGDOM